FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Valeant Pharmaceuticals North America Cardizem CD Recall

Cardizem CD (diltiazem HCl) capsules, 300 mg, packaged in a) 30-count bottles (NDC 0187…

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Feb 20, 2019
Recall ID
D-0490-2019
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled Cardizem CD starting Jan 30, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0490-2019 on Feb 20, 2019. Reason: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Product description

Cardizem CD (diltiazem HCl) capsules, 300 mg, packaged in a) 30-count bottles (NDC 0187-0798-30); and b) 90-count bottles (NDC 0187-0798-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.

Lot numbers, UPCs & expiration codes

Lots: a)18J020P, Exp 08/2020; b) 18J034P, Exp 08/2020

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0490-2019
Classification
Class III
Status
Terminated
Recall initiated
Jan 30, 2019
FDA report date
Feb 20, 2019
Quantity
22 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-0490-2019, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
82021
Address
400 Somerset Corporate Blvd
Code information
Lots: a)18J020P, Exp 08/2020; b) 18J034P, Exp 08/2020
Postal code
08807-2867
Report date
Feb 20, 2019
Product type
Drugs
Recall number
D-0490-2019
Classification
Class III
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
22 bottles
Termination date
Jul 8, 2020
Reason for recall
Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cardizem CD (diltiazem HCl) capsules, 300 mg, packaged in a) 30-count bottles (NDC 0187-0798-30); and b) 90-count bottles (NDC 0187-0798-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Jan 30, 2019
Initial firm notification
Letter
Center classification date
Feb 14, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0490-2019, published Feb 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls